Tag

Asco

All articles tagged with #asco

GLP-1 Diabetes Drugs Hint at Slowing Cancer Spread, Early Observational Findings
health2 days ago

GLP-1 Diabetes Drugs Hint at Slowing Cancer Spread, Early Observational Findings

New findings from the Cleveland Clinic, presented at the ASCO meeting, suggest GLP-1 medications may be linked to reduced metastatic progression in several obesity-related cancers (notably non-small cell lung, breast, colorectal, and liver cancers) when compared with DPP-4 inhibitors. The study is observational and not peer‑reviewed, and it does not prove GLP-1s kill cancer cells or should be used for cancer prevention. Researchers caution that more rigorous, randomized trials are needed before changing cancer treatment guidelines.

GLP-1 diabetes drugs linked to slower cancer progression in early study
health4 days ago

GLP-1 diabetes drugs linked to slower cancer progression in early study

An observational analysis of over 10,000 cancer patients who started GLP-1 drugs after diagnosis found slower progression in four of seven cancers, with the strongest effects in lung and breast cancer, compared with a matched group on DPP-4 inhibitors. The study is not peer‑reviewed and cannot prove causation; randomized trials are needed to confirm any anti‑cancer effects. Researchers discuss possible mechanisms, including tumor GLP-1 receptor interactions, interference with glycolysis, and immune modulation, and conclude GLP-1 drugs appear safe for patients with cancer using them for diabetes or obesity, though they are not a cancer therapy.

"Studies Show Less Intensive Cancer Treatments Can Be More Effective"
health1 year ago

"Studies Show Less Intensive Cancer Treatments Can Be More Effective"

Studies presented at the American Society of Clinical Oncology conference in Chicago show that scaling back treatment for ovarian, esophageal, and Hodgkin lymphoma cancers can improve patients' quality of life without compromising outcomes. The research indicates that less surgery, chemotherapy, or radiation can be just as effective, thanks to advancements in cancer drugs and treatment methods.

Top Stocks to Watch: Apple, NIO, GameStop, and More
finance3 years ago

Top Stocks to Watch: Apple, NIO, GameStop, and More

The week ahead will see a light calendar for major economic releases, with updates on factory orders, consumer credit, and initial jobless claims likely to be the most notable data points. The earnings calendar will feature a few intriguing names like Campbell Soup, DocuSign, and NIO. Meanwhile, the tech sector will be tuned into Apple's WWDC event that could feature an augmented reality headset, new MacBooks, and a first readout from the Cupertino company on how it views the role of AI in the Apple ecosystem. The Chinese electric vehicle maker NIO will report earnings on June 9 with analysts forecasting revenue of $1.68B and EPS of -$0.32 to be disclosed. One of the biggest healthcare conferences of the year, the American Society of Clinical Oncology, will run during the week. Cisco will hold its four-day Cisco Live! IT event in Las Vegas. Steris was singled out this week as an appealing stock pick.